December 12, 2019
December 12, 2019 – The U.S. FDA has approved Amneal
Pharmaceuticals' generic version of Merck's NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring). Amneal’s generic will be marketed under the
name EluRyngTM and is the first generic alternative to NuvaRing to become available on the U.S. market.